PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data

Genomics studies routinely confront researchers with long lists of tumor alterations detected in patients. Such lists are difficult to interpret since only a minority of the alterations are relevant biomarkers for diagnosis and for designing therapeutic strategies. PanDrugs is a methodology that fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Santos, María José, Nogueira-Rodríguez, Alba, Piñeiro-Yáñez, Elena, López-Fernández, Hugo, García-Martín, Santiago, Gómez-Plana, Paula, Reboiro-Jato, Miguel, Gómez-López, Gonzalo, Glez-Peña, Daniel, Al-Shahrour, Fátima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Web Server Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320188/
https://www.ncbi.nlm.nih.gov/pubmed/37207338
http://dx.doi.org/10.1093/nar/gkad412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320188/
https://www.ncbi.nlm.nih.gov/pubmed/37207338
http://dx.doi.org/10.1093/nar/gkad412

Ejemplares similares